Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells
Author:
Funder
Germany Federal Ministry of Education and Research
Publisher
Elsevier BV
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference24 articles.
1. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors;Chou,1984
2. Anti-inflammatory effects of fangchinoline and tetrandrine;Choi;J. Ethnopharmacol.,2000
3. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats;Chen;Int. J. Cancer,2009
4. Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter;Didiodato;Biochem. Pharmacol.,1997
5. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells;Eid;Phytomedicine,2012
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tetrandrine Can Strengthen the Sensitivity and Reverse Drug Resistance of Gastric Carcinoma Organoids and Cells to 5-Fluorouracil;2024
2. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer;Drug Resistance Updates;2023-11
3. Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way;Phytochemistry Reviews;2023-10-11
4. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer;Bioorganic Chemistry;2023-09
5. Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1;Phytomedicine;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3